Noam Solomon is the CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel.
Get the latest insights from The Biotech Startups Podcast delivered straight to your inbox.
Subscribe to our twice-weekly newsletter for updates, news, and more—everything you need to stay ahead in biotech.
.png)
.png)
